Preparation of methanoimidazopyridinones, methanoimidazopyrazinones, and related compounds as modulators of nuclear hormone receptor function.

  • Salvati M
  • Balog J
  • Shan W
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Title compds. [I; G = (substituted)aryl, heterocyclyl; E = C:Z2, CR7CR71, SO2, P:OR2, P:OOR2; Z1, Z2 = O, S, NH, NR6; A1, A2 = CR7, N; Y = JJ1J2; J = (CR7R7)n; n = 0-3; J1 = bond, O, S, SO, SO2, NH, NR6, CO, O2C, NR1C:O, CR7R71, C:CR1R8, R2P:O, OPO2, OSO2, C:N, NHNH, NHNR6, NR6NH, N:N, (substituted) cycloalkyl, cycloalkenyl, heterocyclyl, aryl; J2 = (CR7R71)n; n = 0-3; Y is not a bond; W = CR7R71CR7R71, CRS:CR8, CR7R7CO, NR9CR7R7, N:CR8, N:N, NR9R91, (substituted) cycloalkyl, cycloalkenyl, heterocyclyl, aryl; Q = H, (substituted) alkyl, alkenyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, arylalkyl, alkynyl, aryl, heterocyclyl, halo, CN, R10CO, R4CO, R5R6NC, HOCR7R71, NO2, R10CH2, R10, NH2, C:OSR1, SO2R1, NR4R5; M = bond, O, CR7R71, NR10; M1 = bond, NR10; ≥1 of M, M1 must = bond; L = bond, (CR7R71)n, NH, NR5, N(CR7R71)n; R1 = H, R2; R2 = (substituted) alkyl, cycloalkyl , cycloalkenyl, heterocyclyl, cycloalkylalkyl, cycloalkenylalkyl, heterocycloalkyl, aryl, arylalkyl; R3 = R1, halo, cyano, etc.; R4 = R1, R1CO, R1NHCO etc.; R5 = R2, R1CO, R1NHCO, etc.; R6 = R2, CN, OH, OR1, R1CO, R1NHCO, etc.; R7, R71 = R1, halo, CN, nitro, amino, alkylthio, etc.; R8, R81 = R1, nitro, halo, CN, amino, alkylthio, etc.; R9, R91 = R1, CN, OH, etc.; R10 = CN, OH, OR1, R1CO, etc.; with provisos; and salts thereof] were prepd. as modulators of nuclear hormone receptor function (no data). Thus, 2-azabicyclo[2.2.1]hept-5-ene-3-carboxylic acid Et ester in toluene was treated with 3-(trifluoromethylphenyl)isocyanate followed by heating at 70 °C for 3 h to give the urea deriv. which was heated at 80° with DBU in PhMe to give (5α,8α,8aα)-8,8a-dihydro-2-[3-(trifluoromethyl)phenyl]-5,8-methanoimidazo[1,5-a]pyridine-1,3(2H,5H)-dione II. I and pharmaceutical compns. thereof are useful in the treatment of nuclear hormone receptor-assocd. conditions, such as cancer and immune disorders (no data). [on SciFinder(R)]

Cite

CITATION STYLE

APA

Salvati, M. E., Balog, J. A., Shan, W., Giese, S., & Harikrishnan, L. S. (2004, April 22). Preparation of methanoimidazopyridinones, methanoimidazopyrazinones, and related compounds as modulators of nuclear hormone receptor function. U.S. Pat. Appl. Publ. Bristol-Myers Squibb Company, USA .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free